[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @QueenBioInvest QueenBioInvestor QueenBioInvestor posts on X about $ipsc, $coya, $sgmo, $tlsa the most. They currently have XXX followers and X posts still getting attention that total X engagements in the last XX hours. ### Engagements: X [#](/creator/twitter::783979850138812416/interactions)  - X Week XXX -XX% - X Month XXXXX -XXXX% - X Year XXXXX +1,203% ### Mentions: X [#](/creator/twitter::783979850138812416/posts_active)  - X Week X no change - X Month XX +46% - X Year XX +500% ### Followers: XXX [#](/creator/twitter::783979850138812416/followers)  - X Week XXX no change - X Month XXX +13% - X Year XXX +20% ### CreatorRank: undefined [#](/creator/twitter::783979850138812416/influencer_rank)  ### Social Influence [#](/creator/twitter::783979850138812416/influence) --- **Social category influence** [stocks](/list/stocks) XX% **Social topic influence** [$ipsc](/topic/$ipsc) 40%, [$coya](/topic/$coya) 20%, [$sgmo](/topic/$sgmo) 20%, [$tlsa](/topic/$tlsa) 20%, [breaking news](/topic/breaking-news) 20%, [has been](/topic/has-been) 20%, [$bmy](/topic/$bmy) 20%, [reset](/topic/reset) 20%, [$bmyorbital](/topic/$bmyorbital) XX% **Top accounts mentioned or mentioned by** [@nexttradex](/creator/undefined) [@biotech2k1](/creator/undefined) **Top assets mentioned** [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) ### Top Social Posts [#](/creator/twitter::783979850138812416/posts) --- Top posts by engagements in the last XX hours "Nobel day for immune tolerance Congrats to Mary Brunkow Fred Ramsdell (co-founder & former CSO at Sonoma Biotherapeutics) and Shimon Sakaguchi. Public plays on Tregs/tolerance: $COYA (LD-IL-2/Treg-enhancing) $SGMO (CAR-Treg TX200) $TLSA (intranasal anti-CD3 to induce Tregs)" [X Link](https://x.com/QueenBioInvest/status/1975251400742584815) [@QueenBioInvest](/creator/x/QueenBioInvest) 2025-10-06T17:26Z XXX followers, 3612 engagements "@NextTradeX Yes but different tech. Orbital is in-vivo CAR-T with circular RNA delivered by LNPs (preclin). $IPSC develops allogeneic iPSC-derived NK/T cells ex-vivo now pivoting to autoimmune (CD19). Same immune reset theme different modality and risk. $BMY buying platform optionality" [X Link](https://x.com/QueenBioInvest/status/1976609274156703999) [@QueenBioInvest](/creator/x/QueenBioInvest) 2025-10-10T11:22Z XXX followers, XXX engagements "@NextTradeX no one knows which modality wins. Thats why I size small and wait for proof. $IPSC may be cheap but it still needs clinical traction in autoimmune and clean mfg. Ill buy capitulation and treat $BMY/Orbital as a sector tailwind not a 1:1 read-through" [X Link](https://x.com/QueenBioInvest/status/1976631519905980470) [@QueenBioInvest](/creator/x/QueenBioInvest) 2025-10-10T12:50Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
QueenBioInvestor posts on X about $ipsc, $coya, $sgmo, $tlsa the most. They currently have XXX followers and X posts still getting attention that total X engagements in the last XX hours.
Social category influence stocks XX%
Social topic influence $ipsc 40%, $coya 20%, $sgmo 20%, $tlsa 20%, breaking news 20%, has been 20%, $bmy 20%, reset 20%, $bmyorbital XX%
Top accounts mentioned or mentioned by @nexttradex @biotech2k1
Top assets mentioned Bristol-Myers Squibb Co (BMY)
Top posts by engagements in the last XX hours
"Nobel day for immune tolerance Congrats to Mary Brunkow Fred Ramsdell (co-founder & former CSO at Sonoma Biotherapeutics) and Shimon Sakaguchi. Public plays on Tregs/tolerance: $COYA (LD-IL-2/Treg-enhancing) $SGMO (CAR-Treg TX200) $TLSA (intranasal anti-CD3 to induce Tregs)"
X Link @QueenBioInvest 2025-10-06T17:26Z XXX followers, 3612 engagements
"@NextTradeX Yes but different tech. Orbital is in-vivo CAR-T with circular RNA delivered by LNPs (preclin). $IPSC develops allogeneic iPSC-derived NK/T cells ex-vivo now pivoting to autoimmune (CD19). Same immune reset theme different modality and risk. $BMY buying platform optionality"
X Link @QueenBioInvest 2025-10-10T11:22Z XXX followers, XXX engagements
"@NextTradeX no one knows which modality wins. Thats why I size small and wait for proof. $IPSC may be cheap but it still needs clinical traction in autoimmune and clean mfg. Ill buy capitulation and treat $BMY/Orbital as a sector tailwind not a 1:1 read-through"
X Link @QueenBioInvest 2025-10-10T12:50Z XXX followers, XXX engagements
/creator/twitter::QueenBioInvest